Student Name
Chamberlain University
NR-536: Advanced Health Assessment, Pathophysiology & Pharmacology for Advanced Nursing Practice
Prof. Name:
Date
This case study aims to develop a comprehensive treatment plan to prevent and manage ventilator-associated pneumonia (VAP) in intensive care units (ICU) within acute healthcare settings. Targeted at nursing staff with at least three years of ICU experience, the case study highlights essential concepts such as patient safety, infection control, and evidence-based practices for preventing VAP. Strategies include oral hygiene protocols (Hua et al., 2016), addressing antibiotic resistance (Khan et al., 2017), sedation management, and physical assessment techniques (Álvarez-Lerma et al., 2018). Additional measures such as physiotherapy (Zampieri et al., 2015) and the judicious use of medical devices aim to enhance patient care and minimize the risk of VAP.
The scenario is set in the ICU of an acute care facility, focusing on a patient with respiratory failure who requires oxygen supplementation, intubation, and mechanical ventilation. The patient is under sedation and receives IV anticoagulants, fluid infusions, and continuous monitoring. Equipment includes cardiac and pulmonary monitors, vital sign machines, and wall suction.
Name: Mr. XYZ
Gender/Age/Weight/Height: Male, 65 years, 252 lbs, 5’10”
Allergies: Codeine
Past Medical History: Diabetes, asthma, ischemic stroke (December 2019), paroxysmal atrial fibrillation, coronary artery bypass surgery (2016), 40-pack-year smoking history, and alcohol use.
Present Illness History: Admitted on February 8, 2020, with complaints of tachypnea, shortness of breath, and chest pain. Rapid desaturation led to respiratory distress and subsequent intubation in the emergency department.
Social History: Retired software engineer living with his wife; two adult children reside out of state.
Primary Medical Diagnosis: Pulmonary embolism complicated by pleural effusion, respiratory failure, and hypoxemia.
Surgeries and Procedures: CT scan, blood and urine cultures, arterial blood gas testing, COVID-19 test, daily EKGs, blood tests, and chest X-rays.
Evolving Case Stage | Case Study Information Presented to Learners | Learner Actions and Socratic Questions |
---|---|---|
Stage One | Decline in oxygen levels, requiring increased FiO2/PEEP; tachycardia observed (Hellyer et al., 2016). | Actions: Evaluate medical history, contact the physician, assess the condition, and initiate respiratory management. Socratic Questions: What causes increased oxygen demand? Are further diagnostic tests required? Should early broad-spectrum antibiotics be initiated? |
Stage Two | Increased purulent secretions, frequent suctioning needs, and hypoxemia prompt VAP prevention protocols. | Actions: Implement VAP bundle, perform oral care, elevate head of bed, monitor sedation, and manage endotracheal tube pressure. Socratic Questions: How does oral care lower VAP risk? Is head elevation sufficient to prevent secretions? What alternatives to chlorhexidine are available? |
Stage Three | VAP diagnosis confirmed through imaging and tracheal aspirate; bacterial infection progression noted. | Actions: Narrow antibiotic therapy, assess patient data after 24-48 hours, monitor readiness for weaning, consider probiotics, and perform regular assessments. Socratic Questions: Do sedation management and spontaneous breathing trials reduce VAP? Should antibiotics be narrowed post-culture? What are the benefits of probiotics in such cases? |
Álvarez-Lerma, F., Palomar-Martínez, M., Sánchez-García, M., Martínez-Alonso, M., Álvarez-Rodríguez, J., & Lorente, L. et al. (2018). Prevention of ventilator-associated pneumonia. Critical Care Medicine, 46(2), 181-188. https://doi.org/10.1097/ccm.0000000000002736
Bardia, A., Blitz, D., Dai, F., Hersey, D., Jinadasa, S., Tickoo, M., & Schonberger, R. (2019). Preoperative chlorhexidine mouthwash to reduce pneumonia after cardiac surgery: A systematic review and meta-analysis. The Journal Of Thoracic And Cardiovascular Surgery, 158(4), 1094-1100. https://doi.org/10.1016/j.jtcvs.2019.01.014
Fortaleza, C., Filho, S., Silva, M., Queiroz, S., & Cavalcante, R. (2020). Sustained reduction of healthcare-associated infections after the introduction of a bundle for prevention of ventilator-associated pneumonia in medical-surgical intensive care units. The Brazilian Journal Of Infectious Diseases, 24(5), 373-379. https://doi.org/10.1016/j.bjid.2020.08.004
Hellyer, T., Ewan, V., Wilson, P., & Simpson, A. (2016). the intensive care society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. Journal Of The Intensive Care Society, 17(3), 238-243. https://doi.org/10.1177/1751143716644461
Hua, F., Xie, H., Worthington, H., Furness, S., Zhang, Q., & Li, C. (2016). Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Of Systematic Reviews. https://doi.org/10.1002/14651858.cd008367.pub3
NR 536 Week 5 Develop an Evolving Case Study
Khan, Z., Ceriana, P., & Donner, C. (2017). Ventilator-associated pneumonia or ventilator-induced pneumonia. Multidisciplinary Respiratory Medicine, 12. https://doi.org/10.4081/mrm.2017.224
Olanipekun, T., & Snyder, R. (2019). Mortality risk in ventilator-acquired bacterial pneumonia and nonventilator icu-acquired bacterial pneumonia. Critical Care Medicine, 47(10), e851-e852. https://doi.org/10.1097/ccm.0000000000003662
Pinho, R., Tanure, L., Pessoa, J., Santos, L., Couto, B., & Starling, C. (2020). Impact of each component of a ventilator bundle on preventing ventilator-associated pneumonia and lower respiratory infection. Infection Control & Hospital Epidemiology, 41(S1), s259-s260. https://doi.org/10.1017/ice.2020.824
Prasad, R., Daly, B., & Manley, G. (2019). The impact of 0.2% chlorhexidine gel on oral health and the incidence of pneumonia amongst adults with profound complex neurodisability. Special Care In Dentistry, 39(5), 524-532. https://doi.org/10.1111/scd.12414
Vieira, P., de Oliveira, R., & da Silva Mendonça, T. (2020). Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles?. Medicina Intensiva. https://doi.org/10.1016/j.medin.2020.09.009
Xie, X., Lyu, J., Hussain, F., & Li, M. (2019). Drug prevention and control of ventilator-associated pneumonia. Front Pharmacol, 10(298). https://doi.org/10.3389/fphar.2019.00298
Zampieri, F., Nassar Jr, A., Gusmao-Flores, D., Taniguchi, L., Torres, A., & Ranzani, O. (2015). Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Critical Care, 19(1). https://doi.org/10.1186/s13054-015-0868-y
Zhao, J., Li, L., Chen, C., Zhang, G., Cui, W., & Tian, B. (2020). Do probiotics help prevent ventilator-associated pneumonia in the critically ill patients? A systematic review with meta-analysis. ERJ Open Research, 00302-2020. https://doi.org/10.1183/23120541.00302-2020
Post Categories
Tags